卡拉塔B1增强了Temozolomide对质母细胞瘤细胞的毒性
Samantha L Gerlach1,2, James S Metcalf2,3, Rachael A Dunlop2
1Department of Biology, Dillard University, New Orleans, LA 70122, USA.
Biomedicines
|October 26, 2024
概括
植物衍生型环旋作为质母细胞瘤的辅助疗法非常有前途. 这些化合物使质母细胞瘤细胞对temozolomide具有化学敏感性,这可能会提高这种侵袭性脑癌的治疗疗效.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 质母细胞瘤 (GBM) 是一种具有有限治疗选择的侵袭性脑癌.
- 目前的组合疗法 (手术,辐射,化疗) 显示出低于最佳的疗效.
- 新型辅助疗法对于改善GBM治疗结果至关重要.
研究的目的:
- 为了研究循环胺作为质母细胞细胞的化学敏感剂的潜力.
- 为了评估各种天然和合成环氧化物与temozolomide (TMZ) 结合的疗效.
主要方法:
- 使用UPLC-PDA和HPLC-UV.使用环氧化物 (Cycloviolacin O3,O19,Kalata B1,Vitri E) 的分析.
- 通过轨道飞行LC-MS对合成卡拉塔B1进行序列验证,并通过NMR进行结构确认.
- 在使用TMZ的人类质母细胞瘤细胞系 (U-87 MG,T 98) 中评估环胺细胞毒性和化学敏感化作用.
主要成果:
- 作为单一的药物,环氧化物表现出剂量依赖的细胞毒性 (IC50值2.421.1μM).
- 同时暴露与环类药物显著降低了对质母细胞瘤细胞死亡所需的TMZ度.
- 合成卡拉塔B1表现出强大的化学敏感性,使TMZ剂量分别减少16倍和15倍,对U-87MG和T98细胞.
- 卡拉塔B1在人体血清中显示稳定性.
结论:
- 环氧化物,特别是合成的Kalata B1,可以使质母细胞细胞对temozolomide产生化学敏感性.
- 这些发现表明,环类药物具有作为辅助疗法的潜力,可以增强TMZ在GBM治疗中的疗效.
- 对质母细胞瘤的循环基疗法的进一步研究是有必要的.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


